• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用连续冠状动脉 CT 血管造影对与体重指数相关的冠状动脉斑块进展进行纵向定量评估。

Longitudinal quantitative assessment of coronary plaque progression related to body mass index using serial coronary computed tomography angiography.

机构信息

Division of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.

Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, South Korea.

出版信息

Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):591-599. doi: 10.1093/ehjci/jey192.

DOI:10.1093/ehjci/jey192
PMID:30657884
Abstract

AIMS

This study explored the coronary plaque volume change (PVC) according to the change of percent body mass index (BMI) and categorical BMI group using serial coronary computed tomography angiography (CCTA).

METHODS AND RESULTS

A total of 1568 subjects who underwent serial CCTA with available BMI at baseline (CCTA1) and follow-up (CCTA2) were included. Median inter-scan period was 3.3 (interquartile range: 2.6-4.6) years. Quantitative assessment of coronary plaque was performed at both scans. All participants were categorized into three BMI (kg/m2) groups: normal: <25.0; overweight: 25.0-29.9; and obesity: ≥30.0. During follow-up, there were no significant differences in annualized PVC according to the 5% change of BMI in all BMI groups. Among 1424 (90.8%) subjects in the same BMI group at CCTA1 and CCTA2, a significant difference in annualized (PVC) was observed among the three groups. In 144 (9.2%) subjects with the change in their BMI group at CCTA2 compared their results at CCTA1, annualized PVC was not different compared with subjects in the same BMI group during follow-up. The percent change of BMI was not significantly related to the annualized PVC after adjusting confounding factors. Male gender [odds ratio (OR): 1.38; 95% confidence interval (CI): 1.05-1.81; P = 0.022], baseline plaque volume (OR: 1.07; 95% CI: 1.05-1.09; P < 0.001), and baseline overweight or obesity (OR: 1.35; 95% CI: 1.04-1.77; P = 0.027) were independently associated with coronary plaque progression.

CONCLUSION

Over the near term, longitudinal small changes in BMI were not associated with changes in coronary plaque volume although baseline BMI was.

CLINICAL TRIAL REGISTRATION

ClinicalTrials.gov NCT02803411.

摘要

目的

本研究通过连续冠状动脉计算机断层扫描血管造影(CCTA)探讨体质量指数(BMI)变化百分比和分类 BMI 组的冠状动脉斑块体积变化(PVC)。

方法和结果

共纳入 1568 例连续行 CCTA 且基线(CCTA1)和随访(CCTA2)时均有 BMI 值的患者。两次扫描之间的中位间隔时间为 3.3 年(四分位距:2.6-4.6)。两次扫描均行冠状动脉斑块定量评估。所有患者分为三组 BMI(kg/m2):正常:<25.0;超重:25.0-29.9;肥胖:≥30.0。随访期间,在所有 BMI 组中,BMI 变化 5%与 PVC 的年增长率无显著差异。在 CCTA1 和 CCTA2 时处于同一 BMI 组的 1424 例(90.8%)患者中,三组之间的年化(PVC)差异具有统计学意义。在 CCTA2 时 BMI 组发生变化的 144 例(9.2%)患者中,与 CCTA1 时的结果相比,随访期间与同组 BMI 患者相比,年化 PVC 无差异。调整混杂因素后,BMI 变化百分比与年化 PVC 无显著相关性。男性(比值比[OR]:1.38;95%置信区间[CI]:1.05-1.81;P=0.022)、基线斑块体积(OR:1.07;95%CI:1.05-1.09;P<0.001)和基线超重或肥胖(OR:1.35;95%CI:1.04-1.77;P=0.027)与冠状动脉斑块进展独立相关。

结论

在近期,BMI 的纵向小变化与冠状动脉斑块体积的变化无关,尽管基线 BMI 与之相关。

临床试验注册

ClinicalTrials.gov NCT02803411。

相似文献

1
Longitudinal quantitative assessment of coronary plaque progression related to body mass index using serial coronary computed tomography angiography.利用连续冠状动脉 CT 血管造影对与体重指数相关的冠状动脉斑块进展进行纵向定量评估。
Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):591-599. doi: 10.1093/ehjci/jey192.
2
Longitudinal assessment of coronary plaque volume change related to glycemic status using serial coronary computed tomography angiography: A PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging) substudy.采用连续冠状动脉计算机断层扫描血管造影术评估与血糖状态相关的冠状动脉斑块体积变化的纵向评估:PARADIGM(通过计算机断层扫描血管造影成像确定动脉粥样硬化斑块的进展)子研究。
J Cardiovasc Comput Tomogr. 2019 Mar-Apr;13(2):142-147. doi: 10.1016/j.jcct.2018.12.002. Epub 2018 Dec 17.
3
Quantitative assessment of coronary plaque volume change related to triglyceride glucose index: The Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging (PARADIGM) registry.基于 CT 血管造影成像的动脉粥样硬化斑块进展研究(PARADIGM)注册号:定量评估与甘油三酯葡萄糖指数相关的冠状动脉斑块容积变化。
Cardiovasc Diabetol. 2020 Jul 18;19(1):113. doi: 10.1186/s12933-020-01081-w.
4
Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA.基于 CCTA 的高风险斑块特征和斑块体积对进展为阻塞性病变的差异。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1409-1417. doi: 10.1016/j.jcmg.2019.09.011. Epub 2019 Nov 13.
5
Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study.基于高危斑块特征的他汀类药物对轻度狭窄病变中冠状动脉斑块进展的影响:PARADIGM 研究结果。
Eur Heart J Cardiovasc Imaging. 2023 Oct 27;24(11):1536-1543. doi: 10.1093/ehjci/jead110.
6
Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry.血糖控制与基线冠状动脉斑块负担无关,与冠状动脉粥样硬化快速进展独立相关:来自 PARADIGM 注册研究的回顾性病例对照研究。
Cardiovasc Diabetol. 2022 Nov 12;21(1):239. doi: 10.1186/s12933-022-01656-9.
7
Differential association between the progression of coronary artery calcium score and coronary plaque volume progression according to statins: the Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging (PARADIGM) study.根据他汀类药物的不同,冠状动脉钙评分进展与冠状动脉斑块体积进展之间的关联存在差异:由计算机断层血管造影成像确定的动脉粥样硬化斑块进展研究(PARADIGM 研究)。
Eur Heart J Cardiovasc Imaging. 2019 Nov 1;20(11):1307-1314. doi: 10.1093/ehjci/jez022.
8
Association between Aortic Valve Calcification Progression and Coronary Atherosclerotic Plaque Volume Progression in the PARADIGM Registry.PARADIGM 注册研究中主动脉瓣钙化进展与冠状动脉粥样硬化斑块体积进展的相关性。
Radiology. 2021 Jul;300(1):79-86. doi: 10.1148/radiol.2021202630. Epub 2021 May 11.
9
The impact of baseline calcified plaque volume on coronary rapid plaque progression by serial coronary computed tomography angiography in patients with type 2 diabetes.2 型糖尿病患者连续冠状动脉计算机断层血管造影对基线钙化斑块体积对冠状动脉快速斑块进展的影响。
Ann Med. 2023 Dec;55(1):2196438. doi: 10.1080/07853890.2023.2196438.
10
Effects of statin therapy on progression of mild noncalcified coronary plaque assessed by serial coronary computed tomography angiography: A multicenter prospective study.通过连续冠状动脉计算机断层扫描血管造影评估他汀类药物治疗对轻度非钙化冠状动脉斑块进展的影响:一项多中心前瞻性研究。
Am Heart J. 2016 Oct;180:29-38. doi: 10.1016/j.ahj.2016.06.023. Epub 2016 Jul 14.

引用本文的文献

1
Assessment of Normal Systolic Blood Pressure Maintenance with the Risk of Coronary Artery Calcification Progression in Asymptomatic Metabolically Healthy Korean Adults with Normal Weight, Overweight, and Obesity.体重正常、超重和肥胖的无症状代谢健康韩国成年人中,正常收缩压维持情况与冠状动脉钙化进展风险的评估
J Clin Med. 2023 May 31;12(11):3770. doi: 10.3390/jcm12113770.
2
Predicting Coronary Stenosis Progression Using Plaque Fatigue From IVUS-Based Thin-Slice Models: A Machine Learning Random Forest Approach.使用基于血管内超声(IVUS)的薄片模型中的斑块疲劳预测冠状动脉狭窄进展:一种机器学习随机森林方法。
Front Physiol. 2022 May 10;13:912447. doi: 10.3389/fphys.2022.912447. eCollection 2022.
3
CAD-RADS may underestimate coronary plaque progression as detected by serial CT angiography.
CAD-RADS 可能低估了通过连续 CT 血管造影检测到的冠状动脉斑块进展。
Eur Heart J Cardiovasc Imaging. 2022 Oct 20;23(11):1530-1539. doi: 10.1093/ehjci/jeab215.
4
Longitudinal Progression of Subclinical Coronary Atherosclerosis in Swiss HIV-Positive Compared With HIV-Negative Persons Undergoing Coronary Calcium Score Scan and CT Angiography.瑞士HIV阳性与HIV阴性人群在接受冠状动脉钙化评分扫描和CT血管造影时亚临床冠状动脉粥样硬化的纵向进展比较
Open Forum Infect Dis. 2020 Sep 16;7(10):ofaa438. doi: 10.1093/ofid/ofaa438. eCollection 2020 Oct.